Cohen & Steers, Inc. Biogen Inc. Transaction History

Cohen & Steers, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $7.42 Million - $9.39 Million	-26,628 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $9.59 Million - $12.5 Million	-32,684 Reduced 55.11%	26,628 $9.41 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $584,055 - $696,071	-2,268 Reduced 3.68%	59,312 $17.2 Million
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $1.18 Million - $1.67 Million	4,545 Added 7.97%	61,580 $16.9 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $5.64 Million - $6.32 Million	18,340 Added 47.4%	57,035 $18.2 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $10.9 Million - $12.8 Million	38,695	38,695 $12.1 Million

995

131M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Cohen & Steers, Inc., based on Form 13F filings with the SEC.

Stay updated on Cohen & Steers, Inc. with notifications on news.